Skip to content

Effectiveness of Siddha Medicines on COVID-19 patients

Effectiveness of Siddha Herbal Formulations (Notchi Kudineer and Chitrarathai Kudineer) on SARS-CoV-2 infection among asymptomatic infected patients - COSID

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/12/029869
Enrollment
90
Registered
2020-12-16
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere Health Condition 2: B998- Other infectious disease

Interventions

Intervention1: Notchi Kudineer Arathai Kudineer: Decoction to be given 60 ml dose, thrice a day, for 14 days Intervention2: Notchi Kudineer Standard of care: Siddha Herbal Decoction 60 ml thrice a day

Sponsors

MINISTRY OF AYUSH GOVERNMENT OF INDIA
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: A person diagnosed with COVID-19 in the past 48 hours and undergoing treatment at Government Chengalpattu Medical College, Tamilnadu

Exclusion criteria

Exclusion criteria: Chronic lung disease with chronic hypoxia ï?· Sleep apnea requiring BIPAP / continuous positive airway pressure ï?· Other conditions which are considered not suitable for herbal drug trial as allergic to herbal medicine etc ï?· Pregnancy ï?· People who are part of other COVID-19 trials

Design outcomes

Primary

MeasureTime frame
Reduction in severity of symptoms ï?· Status of infection â?? Positive /Negative - through (SARS-CoV-2 / COVID-19) N-Protein IgM / IgG antibodies in human serum, whole blood, or finger prick samples Timepoint: 5 days

Secondary

MeasureTime frame
ï?· Increase in the SARS- CoV-2 specific antibodies titer at the end of treatment ï?· Immune markers and inflammatory markers (Immunoglobulins, TNF-Alfa, IL6, IL10) at the end of treatment ï?· Reduction in duration of hospitalization Timepoint: 14 days

Countries

India

Contacts

Public ContactN KABILAN

The Tamil Nadu Dr.M.G.R. Medical University

kabilan.n@tnmgrmu.ac.in9444018139

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026